Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Items 201–300 of 817
Kuppermann, M., Norton, M. E., Thao, K., O’Leary, A., Nseyo, O., Cortez, A., & Kaimal, A. J. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4808 · Cited by 28
Self-citationCurrent landscape of prenatal genetic screening and testing
Krstić, N., & Običan, S. G. (2019) · Birth Defects Research · doi:10.1002/bdr2.1598 · Cited by 34
Peng, X., Li, H., Wu, F., & Wang, J. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa060 · Cited by 30
Prenatal aneuploidy screening using cell free DNA
Oepkes, D., Tabor, A., & Yaron, Y. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.06.025 · Cited by 28
Michelson, J., Rausser, S., Peng, A., Yu, T., Sturm, G., Trumpff, C., Kaufman, B. A., Rai, A. J., & Picard, M. A. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.05.001 · Cited by 29
Oxenford, K., Daley, R., Lewis, C., Hill, M. K., & Chitty, L. S. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1315-7 · Cited by 34
Kolarova, T. R., Gammill, H. S., Nelson, J. L., Lockwood, C. M., & Shree, R. S. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021477 · Cited by 30
Dai, P., Yang, Y., Zhao, G., Gu, Z., Ren, H., Hu, S., Liu, N., Jiao, W., Li, J., & Kong, X. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03455-y · Cited by 31
Yared, E., Dinsmoor, M. J., Endres, L. K., Berg, M. J. V., Hoell, C., Lapin, B. R., & Plunkett, B. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.018 · Cited by 30
Hui, C., Tan, W. C., Tan, E., & Tan, L. K. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-216593 · Cited by 27
Kinetics of Plasma Cell-Free DNA and Creatine Kinase in a Canine Model of Tissue Injury
Wilson, I. J., Burchell, R. K., Worth, A. J., Burton, S. E., Gedye, K. R., Clark, K. J., Crosse, K. R., Jack, M., Odom, T. F., Grey, S. J. D., et al. (2017) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14901 · Cited by 27
Systematic Review of Accuracy Differences in NIPT Methods for Common Aneuploidy Screening
Marton, T., Erdélyi, Z. R., Takai, M., Mészáros, B., Supák, D., Ács, N., Kukor, Z., Herold, Z., Hargitai, B., & Valent, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082813 · Cited by 31
Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes
Shaffer, B. L., & Norton, M. E. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2017.10.001 · Cited by 28
Self-citationCosta, J., Letourneau, A., Favre, R., Bidat, L., Belaisch-Allart, J. C., Jouannic, J., Quarello, E., Sénat, M., Broussin, B., Tsatsaris, V., et al. (2018) · Genetics in Medicine · doi:10.1038/gim.2018.4 · Cited by 29
Lai, Y., Zhu, X., he, S. T., Dong, Z., Tang, Y., Xu, F., Chen, Y., Meng, L., Tao, Y., Yi, S., et al. (2021) · Genes · doi:10.3390/genes12040478 · Cited by 27
Yang, H., He, J., Huang, S., Yang, H., Yi, Q., Tao, Y., Chen, M., Zhang, X., & Qi, H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.780779 · Cited by 29
Haidar, H., Vanstone, M. G., Laberge, A., Bibeau, G., Ghulmiyyah, L., & Ravitsky, V. (2018) · AJOB Empirical Bioethics · doi:10.1080/23294515.2018.1469551 · Cited by 35
Dyr, B., Boomer, T., Almasri, E. A., Wardrop, J., Rafalko, J. M., Chibuk, J., & McCullough, R. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220979 · Cited by 26
Dervan, A., Deverka, P. A., Trosman, J. R., Weldon, C. B., Douglas, M. P., & Phillips, K. A. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.145 · Cited by 26
Expanded conventional first trimester screening
Carmichael, J. B., Liu, H., Janik, D., Hallahan, T., Nicolaides, K. H., & Krantz, D. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5090 · Cited by 29
Donor-specific cell-free DNA as a biomarker in liver transplantation: A review
McClure, T., Goh, S. K., Cox, D. R. A., Muralidharan, V., Dobrovic, A., & Testro, A. (2020) · World Journal of Transplantation · doi:10.5500/wjt.v10.i11.307 · Cited by 29
Brewer, J., Demers, L., & Musci, T. J. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1225035 · Cited by 25
Self-citationFlöck, A., Tu, N.-C., Rüland, A. M., Holzgreve, W., Gembruch, U., & Geipel, A. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4517-3 · Cited by 25
Cell-free DNA for the detection of fetal aneuploidy
Goldwaser, T., & Klugman, S. D. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.12.019 · Cited by 27
Patients’ Knowledge of Prenatal Screening for Trisomy 21
Sheinis, M., Bensimon, K., & Selk, A. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0126-3 · Cited by 24
Yang, L., & Tan, W. C. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03279-y · Cited by 27
The impact of maternal autoimmune disease on cell-free DNA test characteristics
MacKinnon, H. J., Kolarova, T. R., Katz, R., Hedge, J. M., Vinopal, E., Lockwood, C. M., Shree, R. S., & Delaney, S. S. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100466 · Cited by 29
Corvigno, S., Johnson, A. M., Wong, K., Cho, M. S., Afshar‐Kharghan, V., Menter, D. G., & Sood, A. K. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0087 · Cited by 25
Chen, K. M., White, K. L., Shabbeer, J., & Schmid, M. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1481033 · Cited by 28
Tian, C., Deng, T., Zhu, X., Chen, G., Zhao, Y., Wei, Y., Li, R., Xu, X., He, M., Zhang, Z., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-9600-0 · Cited by 27
Noninvasive monitoring of acute and chronic rejection in heart transplantation
Crespo‐Leiro, M. G., Barge‐Caballero, G., & Couto‐Mallón, D. (2017) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000400 · Cited by 23
Ma, G., Lin, W., Huang, C.-E., Chang, T., Liu, J., Yang, Y.-J., Lee, M., Wu, W.-J., Chang, Y.-S., & Chen, M. (2019) · Micromachines · doi:10.3390/mi10020132 · Cited by 23
Shree, R. S., Kolarova, T. R., MacKinnon, H. J., Hedge, J. M., Vinopal, E., Ma, K. K., Lockwood, C. M., & Chandrasekaran, S. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6023 · Cited by 24
Emerging and Disruptive Technologies
Crowe, A. S. (2015) · CRC Press eBooks · doi:10.1201/b18476-7 · Cited by 23
Chang, M. Y., Kim, A. R., Kim, M. Y., Kim, S., Yoon, J., Han, J. J., Ahn, S., Kang, C. P., & Choi, B. Y. (2016) · Scientific Reports · doi:10.1038/srep37153 · Cited by 23
Deans, Z. C., Allen, S. K., Jenkins, L., Khawaja, F., Hastings, R. J., Mann, K., Patton, S. J., Sistermans, E. A., & Chitty, L. S. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5068 · Cited by 22
The significance of trisomy 7 mosaicism in noninvasive prenatal screening
Qi, Y., Yang, J., Hou, Y., Guo, F., Peng, H., Wang, D., Du, Q.-Y., & Yin, A. (2019) · Human Genomics · doi:10.1186/s40246-019-0201-y · Cited by 23
A method for noninvasive prenatal diagnosis of monogenic autosomal recessive disorders
Cutts, A., Vavoulis, D. V., Petrou, M., Smith, F., Clark, B. E., Henderson, S. J., & Schuh, A. (2019) · Blood · doi:10.1182/blood.2019002099 · Cited by 24
Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births
Gomez‐Lopez, N., Romero, R. J., Schwenkel, G., Garcia‐Flores, V., Panaitescu, B., Varrey, A., Ayoub, F., Hassan, S. S., & Phillippe, M. (2020) · Reproductive Sciences · doi:10.1007/s43032-019-00023-6 · Cited by 26
Borth, H., Teubert, A., Glaubitz, R., Knippenberg, S., Kutur, N., Winkler, T., & Eiben, B. (2020) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-020-05856-0 · Cited by 25
Norton, M. E., MacPherson, C., Demko, Z., Egbert, M., Malone, F. D., Wapner, R. J., Roman, A. S., Khalil, A. A., Faro, R., Madankumar, R., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.03.026 · Cited by 28
Self-citationBENN, P. A., & Cuckle, H. (2023) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000803 · Cited by 24
Self-citationParham, L., Michie, M., & Allyse, M. A. (2017) · Current Genetic Medicine Reports · doi:10.1007/s40142-017-0113-x · Cited by 25
Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening
Gray, K. J., & Wilkins-Haug, L. E. (2018) · Pediatric Radiology · doi:10.1007/s00247-017-3958-y · Cited by 23
Wilkins-Haug, L. E., Zhang, C., Cerveira, E., Ryan, M., Mil-Homens, A., Zhu, Q., Reddi, H. V., Lee, C., & Bianchi, D. W. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5260 · Cited by 22
Amsterdam, K. H., Page‐Christiaens, L., Flowers, N. J., Bonifacio, M., Ellis, K. B., Vogel, I., Vestergaard, E. M., Miguelez, J., de Carvalho, M. H. B., Sistermans, E. A., et al. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0188-1 · Cited by 24
Novel perspectives in fetal biomarker implementation for the noninvasive prenatal testing
Shi, J., Zhang, R., Li, J., & Zhang, R. (2019) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1631749 · Cited by 25
Demko, Z., Prigmore, B., & BENN, P. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164760 · Cited by 26
Steinbach, R. J., Allyse, M. A., Michie, M., Liu, E. Y., & Cho, M. K. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37459 · Cited by 26
Persico, N., Boito, S., Ischia, B., Cordisco, A., Robertis, V. D., Fabietti, I., Periti, E., Volpe, P., Fedele, L., & Rembouskos, G. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4773 · Cited by 21
ACMG 2016 Update on Noninvasive Prenatal Testing for Fetal Aneuploidy: Implications for India
Verma, I. C., Puri, R. D., & Bijarnia‐Mahay, S. (2017) · Journal of Fetal Medicine · doi:10.1007/s40556-017-0116-4 · Cited by 21
Lee, D. E., Kim, H., Park, J., Yun, T., Park, D. Y., Kim, M. H., & Ryu, H. M. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e172 · Cited by 26
Prenatal diagnosis of Down syndrome: A 13-year retrospective study
Vičić, A., Hafner, T., Vlatković, I. B., Korać, P., Habek, D., & Stipoljev, F. (2017) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2017.10.004 · Cited by 24
Moving Towards Routine Non-Invasive Prenatal Testing (NIPT): Challenges Related to Women’s Autonomy
Birko, S., Lemoine, M., Nguyen, M. T., & Ravitsky, V. (2018) · OBM Genetics · doi:10.21926/obm.genet.1802018 · Cited by 26
Prenatal Screening for Fetal Aneuploidy
Langlois, S., & Wilson, R. D. (2017) · OBM Genetics · doi:10.21926/obm.genet.1703007 · Cited by 21
How does emerging patent case law in the US and Europe affect precision medicine?
Aboy, M., Liddell, K., Crespo, C., Cohen, I. G., Liddicoat, J., Gerke, S., & Minssen, T. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0265-1 · Cited by 20
The current state of prenatal detection of genetic conditions in congenital heart defects
Findley, T. O., & Northrup, H. (2021) · Translational Pediatrics · doi:10.21037/tp-20-315 · Cited by 23
Noninvasive prenatal diagnosis targeting fetal nucleated red blood cells
Chen, Y., Wu, Z., Sutlive, J., Wu, K., Mao, L., Nie, J., Zhao, X., Guo, F., Chen, Z., & Huang, Q. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01749-3 · Cited by 25
Xiang, L., Zhu, J., Deng, K., Li, Q., Tao, J., Li, M., Wang, Y., Yuan, X., Yao, Y., & Li, X. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6312 · Cited by 25
Song, Y., Zhou, X., Huang, S., Li, X., Qi, Q., Jiang, Y., Liu, Y., Ma, C., Li, Z., Xu, M., et al. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.03.005 · Cited by 20
Pre-Implantation Genetic Screening Techniques: Implications for Clinical Prenatal Diagnosis
Kane, S. C., Willats, E., Moura, S. B. M. E. H., Hyett, J. A., & Costa, F. D. S. (2016) · Fetal Diagnosis and Therapy · doi:10.1159/000449381 · Cited by 20
Jin, J.-J., Yang, J., Chen, Y., & Huang, J. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5111 · Cited by 20
Informative priors on fetal fraction increase power of the noninvasive prenatal screen
Xu, H., Wang, S., Ma, L., Huang, S., Liang, L., Liu, Q., Liu, Y., Liu, K., Tan, Z.-M., Ban, H., et al. (2017) · Genetics in Medicine · doi:10.1038/gim.2017.186 · Cited by 20
Clinical application of noninvasive prenatal testing in the detection of fetal chromosomal diseases
Pang, Y., Chaohong, W., Tang, J., & Zhu, J. (2021) · Molecular Cytogenetics · doi:10.1186/s13039-021-00550-5 · Cited by 23
DiNonno, W., Demko, Z., Martin, K. A., Billings, P. R., Egbert, M., Zneimer, S. M., Keen‐Kim, D., & BENN, P. A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091311 · Cited by 19
Zou, Y., Cui, L., Xue, M., Yan, J., Huang, M., Gao, M. J., Gao, X., Gao, Y., & Chen, Z. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5836 · Cited by 21
Establishing and validating noninvasive prenatal testing procedure for fetal aneuploidies in Vietnam
Phan, M., Nguyen, T. V., Trinh, H. N. T., Vo, B. T., Nguyen, T. M., Nguyen, N. H., Nguyen, T. T. Q., Thuy, T. T., Hoang, T. T. D., Truong, K. D., et al. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1481032 · Cited by 21
Cost-Effectiveness Analysis of Non-invasive Prenatal Testing for Down Syndrome in China
Xu, Y., Wei, Y., Ming, J., Li, N., Xu, N., Pong, R., & Chen, Y. (2019) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462319000308 · Cited by 19
Xie, X., Tan, W., Li, F., Carrano, E., Ramirez, P., DiAdamo, A., Grommisch, B., Amato, K., Chai, H., Wen, J., et al. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1297 · Cited by 19
Guy, G. P., Hargrave, J., Dunn, R., Price, K. M., Short, J., Thilaganathan, B., & collaborative, T. S. T. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16464 · Cited by 20
Impact of mosaicism ratio on positive predictive value of cfDNA screening
Rafalko, J. M., Caldwell, S., Tynan, J. A., Almasri, E., Weinblatt, V. J., & McCullough, R. M. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5863 · Cited by 19
Qasemi, M., Mahdian, R., & Amidi, F. (2021) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-02038-4 · Cited by 22
Improving the Positive Predictive Value of Non-Invasive Prenatal Screening (NIPS)
Strom, C. M., Anderson, B., Tsao, D., Zhang, K., Liu, Y., Livingston, K., Elzinga, C. D., Evans, M., Nguyen, Q., Wolfson, D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0167130 · Cited by 20
Zhao, G., Dai, P., Wang, C., Liu, L., Zhao, X., & Kong, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.672211 · Cited by 18
Zheng, Y., Li, J., Zhang, J., & Hong, Y. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24660 · Cited by 20
BENN, P. A., & Chapman, A. R. (2016) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000254 · Cited by 30
Li, H., Yu, L., Zhu, H., Luo, Y., Qian, Y., Chen, M., Sun, Y., Yan, K., Yang, Y., Liu, B., et al. (2018) · Molecular Cytogenetics · doi:10.1186/s13039-018-0407-z · Cited by 18
Evaluation of droplet digital PCR for non-invasive prenatal diagnosis of phenylketonuria
Yan, Y., Wang, F., Zhang, C., Jin, X., Zhang, Q., Feng, X., Hao, S., Gao, H., & Ma, X. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02087-4 · Cited by 17
Variability of “Reported Fetal Fraction” in Noninvasive Prenatal Screening (NIPS)
Persson, F., & Prensky, L. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab014 · Cited by 18
Dougan, S., Okun, N. B., Bellai‐Dussault, K., Meng, L., Howley, H. E. A., Huang, T., Reszel, J., Lanes, A., WALKER, M. C., & Armour, C. M. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.202456 · Cited by 21
Society for Maternal‐Fetal Medicine (SMFM), Rink, B. D., Dugoff, L., & Kuller, J. A. (2025) · Pregnancy · doi:10.1002/pmf2.70139 · Cited by 36
COFFEE: control‐free noninvasive fetal chromosomal examination using maternal plasma DNA
Sun, K., Chan, K. C. A., Hudecova, I., Chiu, R. W. K., Lo, Y. M. D., & Jiang, P. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5016 · Cited by 17
Liu, S., Chang, Q., Yang, F., Xu, Y., Jia, B., Wu, R., Li, L., Yin, A., Chen, W., Huang, F., et al. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-022-06908-3 · Cited by 21
Zhang, H., Zhao, Y., Song, J., Zhu, Q., Yang, H., Zheng, M., Xuan, Z., Wei, Y., Chen, Y., Yuan, P., et al. (2015) · Scientific Reports · doi:10.1038/srep16106 · Cited by 17
Bianchi, D. W. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4993 · Cited by 17
Cheng, Y., Leung, W., Leung, T., Choy, K. W., Chiu, R., Lo, T., Kwok, K., & Sahota, D. S. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15022 · Cited by 18
Guy, C., Sheikhi, F. H., Rowland, C. M., Anderson, B., Owen, R. X., Lacbawan, F. L., & Alagia, D. P. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.545 · Cited by 17
Obesity and no call results: optimal timing of cell-free DNA testing and redraw
Hopkins, M. K., Koelper, N., Caldwell, S., Dyr, B., & Dugoff, L. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.04.212 · Cited by 25
Lu, Y.-S., Chen, Y., Ding, S., Zeng, L., Shi, L., Li, Y., Zhang, J., Fu, J. X., Zhou, S.-H., & He, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33437 · Cited by 19
Hochstenbach, R., Christiaens, G. C. M. L., van Oppen, A. C. C., Lichtenbelt, K. D., van Harssel, J. J. T., Brouwer, T., Manten, G. T. R., van Zon, P. H. A., Elferink, M., Kusters, K., et al. (2015) · Case Reports in Genetics · doi:10.1155/2015/926545 · Cited by 16
Chloe’s Law: A Powerful Legislative Movement Challenging a Core Ethical Norm of Genetic Testing
Caplan, A. L. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002219 · Cited by 16
Zhang, R., Zhang, H., Li, Y., Han, Y., Xie, J., & Li, J. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.10.003 · Cited by 16
Predicting therapy response and resistance in metastatic prostate cancer with circulating tumor DNA
Ritch, E. J., & Wyatt, A. W. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.11.017 · Cited by 16
Stakeholders’ views on the value of outcomes from clinical genetic and genomic interventions
Scheuner, M. T., Russell, M. M., Coffinier, C., Peredo, J., Yano, E. M., Hamilton, A. B., Lerner, B., Provenzale, D., Knight, S. J., & Voils, C. I. (2018) · Genetics in Medicine · doi:10.1038/s41436-018-0344-6 · Cited by 18
Monni, G., Corda, V., Iuculano, A., & Afshar, Y. (2020) · Journal of Perinatal Medicine · doi:10.1515/jpm-2020-0035 · Cited by 19
The Necessity of Prenatal Diagnosis by CMA for the Women with NIPS-Positive Results
Xu, J., Xue, Y., Wang, J., Zhou, Q., Zhang, B., Yu, B., & Wang, T. (2020) · International Journal of Genomics · doi:10.1155/2020/2145701 · Cited by 17
Ling, D. I., Lynd, L. D., Harrison, M. J., Anis, A. H., & Bansback, N. J. (2018) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2018-0033 · Cited by 20
Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells
Chen, P., Teng, P., Zhu, Y., Jan, Y. J., Smalley, M. D., Afshar, Y., Chen, L.-C., Pisarska, M. D., & Tseng, H. (2019) · Current Obstetrics and Gynecology Reports · doi:10.1007/s13669-019-0254-x · Cited by 16
Calculation of Fetal Fraction for Non-Invasive Prenatal Testing
Cserhati, M. (2021) · BioTech · doi:10.3390/biotech10030017 · Cited by 16
Hui, L. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15845 · Cited by 15
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.